The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Salvage radiotherapy (SRT) in combination with pembrolizumab in patients with PSA persistence or biochemical recurrence after radical prostatectomy due to prostate cancer.
 
Markus Grabbert
Consulting or Advisory Role - Apogepha; Astellas Pharma; Bristol-Myers Squibb; Eisai; Ipsen; Janssen-Cilag; Medac; Merck Sharp & Dohme Oncology; Roche
Travel, Accommodations, Expenses - Astellas Pharma; Janssen-Cilag
 
Constantinos Zamboglou
No Relationships to Disclose
 
Annika Josef
No Relationships to Disclose
 
August Sigle
No Relationships to Disclose
 
Simon K.B. Spohn
No Relationships to Disclose
 
Anca L. Grosu
No Relationships to Disclose
 
Christian Gratzke
Consulting or Advisory Role - Amgen Astellas BioPharma; Astellas Pharma; Bayer; GlaxoSmithKline; Ipsen; Janssen-Cilag; Lilly; Pfizer; Recordati; Rottapharm Biotech; Steba Biotech
Research Funding - Astellas Pharma; Bayer; GlaxoSmithKline; MSD; Recordati